Cholesterol lower in chronic hepatitis B

    Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
    |September 30, 2016
    PubMed

    Insights

    Chronic hepatitis B infection may explain the inverse relationship between blood cholesterol levels and liver disease. This finding is crucial for understanding liver disease progression and cholesterol metabolism.

    Area of Science:

    • Hepatology
    • Infectious Diseases
    • Biochemistry

    Background:

    • A negative correlation between blood cholesterol and liver disease has been observed.
    • The underlying mechanisms for this association remain unclear.
    • Chronic hepatitis B infection is a significant global health concern.

    Purpose of the Study:

    • To investigate whether chronic hepatitis B infection mediates the inverse association between blood cholesterol and liver disease.
    • To elucidate the role of hepatitis B virus (HBV) in cholesterol metabolism in the context of liver disease.

    Main Methods:

    • Retrospective cohort study design.
    • Analysis of patient data including cholesterol levels, liver function tests, and HBV status.
    • Statistical modeling to assess the association between HBV infection, cholesterol, and liver disease markers.

    Main Results:

    • A significant inverse association was found between blood cholesterol concentration and markers of liver disease.
    • This association was significantly attenuated after adjusting for chronic hepatitis B infection status.
    • Patients with chronic hepatitis B infection showed distinct cholesterol profiles compared to uninfected individuals.

    Conclusions:

    • Chronic hepatitis B infection appears to be a key factor explaining the inverse association between blood cholesterol and liver disease.
    • HBV infection may alter cholesterol metabolism, influencing disease presentation and progression.
    • Further research into HBV-mediated cholesterol dysregulation is warranted for therapeutic strategies.

    Related Concept Videos

    Cholesterol: Significance and Regulation01:29

    Cholesterol: Significance and Regulation

    Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
    Considering cholesterol and...
    1.8K
    Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

    Blood Studies for Cardiovascular System III: Serum Lipid Profile

    Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
    Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
    Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
    740
    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

    Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

    In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
    248
    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

    Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

    Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
    310
    Chronic Bowel Disorders: Introduction01:17

    Chronic Bowel Disorders: Introduction

    Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
    Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
    873
    Hepatic Drug Excretion: Influencing Factors01:16

    Hepatic Drug Excretion: Influencing Factors

    The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
    704